Estimating the serological underrecognition of patients with weak or partial RHD variants
Transfusion · 2024-05 · 64 (5) · 920-928
DOI: 10.1111/trf.17810 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 18.04.2024. Verfasst von Glenn Ramsey und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Gene Frequency, Rh-Hr Blood-Group System. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
For patients with weak or discrepant RhD RBC phenotypes, RHD genotyping is employed to determine need for RhD‐negative management. However, many RHD variants are type D‐negative or D‐positive. Serological recognition rates (RRs) of weak and partial RHD variants are poorly characterized. Study Design and Methods Four US studies employing RHD genotyping for weak or discrepant RhD phenotypes provided data for race/ethnicity‐specific serological recognition. Three studies used microplate, and 1 used gel and tube; 2 had anti‐D data. We obtained White and Hispanic/Latino allele frequencies (AFs) of weak D types 1, 2, and 3 single‐nucleotide variants (SNVs) from the Genome Aggregation Database (gnomAD, v4.0.0) and devised Hardy–Weinberg‐based formulas to correct for gnomAD's overcount of hemizygous RHD SNVs as homozygous. We compiled common partial RHD AF from genotyped cohorts of US Black or sickle cell disease subjects. From variant AF, we calculated hemizygous‐plus‐homozygous genetic prevalences. Serological prevalence: genetic prevalence ratios yielded serological RRs.
Results
Overall RRs of weak D types 1–3 were 17% (95% confidence interval 12%–24%) in Whites and 12% (5%–27%) in Hispanics/Latinos. For eight partial RHD variants in Blacks, overall RR was 11% (8%–14%). However, DAR RR was 80% (38%–156%). Compared to microplate, gel–tube recognition was higher for type 2 and DAU5 and lower for type 4.0. Anti‐D was present in 6% of recognized partial RHD cases, but only in 0.7% of estimated total genetic cases.
Discussion
Based on AF, >80% of patients with weak or partial RHD variants were unrecognized serologically. Although overall anti‐D rates were low, better detection of partial RHD variants is desirable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Blood Bank, Northwestern Memorial Hospital, Chicago, Illinois, USA.
- Division of Hematology and Oncology, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Blood Bank, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
ORCID-Profile: Glenn Ramsey, Christina M Barriteau
Zitieren
APA
Ramsey, G., & Barriteau, C. M. (2024). Estimating the serological underrecognition of patients with weak or partial RHD variants. Transfusion, 64(5), 920-928. https://doi.org/10.1111/trf.17810
Vancouver
Ramsey G, Barriteau CM. Estimating the serological underrecognition of patients with weak or partial RHD variants. Transfusion. 2024;64(5):920-928. doi:10.1111/trf.17810
BibTeX
@article{Ramsey2024,
author = {Ramsey, Glenn and Barriteau, Christina M},
title = {Estimating the serological underrecognition of patients with weak or partial RHD variants},
journal = {Transfusion},
year = {2024},
volume = {64},
number = {5},
pages = {920--928},
doi = {10.1111/trf.17810}
}
EUVIMED